Upsalite® as a solubility improver for Active Pharmaceutical Ingredients (APIs)

- Upsalite®has proven great potential

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Upsalite®has proven great potential for development of new formulations of these rejected drugs. Read the article: http://www.sciencedirect.com/science/article/pii/S0378517314004451. Or read the press release http://www.mynewsdesk.com/uk/uu/pressreleases/supermaterial-gives-rejected-drugs-a-new-chance-1033639